These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19572232)

  • 41. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of clinical information in patients with gastroenteropancreatic neuroendocrine tumor.
    Kudo A; Akashi T; Kumagai J; Ban D; Inokuchi M; Kojima K; Kawano T; Tanaka S; Arii S
    Hepatogastroenterology; 2012; 59(120):2450-3. PubMed ID: 22584507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
    Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
    Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.
    Le Roux C; Lombard-Bohas C; Delmas C; Dominguez-Tinajero S; Ruszniewski P; Samalin E; Raoul JL; Renard P; Baudin E; Robaskiewicz M; Mitry E; Cadiot G;
    Dig Liver Dis; 2011 Oct; 43(10):828-33. PubMed ID: 21641888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
    Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
    Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.
    Amarapurkar DN; Juneja MP; Patel ND; Amarapurkar AD; Amarapurkar PD
    Trop Gastroenterol; 2010; 31(2):101-4. PubMed ID: 20862983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
    Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
    Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
    ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
    Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
    Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
    Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
    Burke AP; Thomas RM; Elsayed AM; Sobin LH
    Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
    Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Surgical prognostic factors of gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Medrano-Guzmán R; Alvarado-Cabrero I; González-Rodríguez D; López-García SC; Páez-Agraz F
    Rev Med Inst Mex Seguro Soc; 2012; 50(3):243-8. PubMed ID: 23182252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases.
    Stoica-Mustafa E; Pechianu C; Iorgescu A; Hortopan M; Dima SO; Tomulescu V; Dumitraşcu T; Ungureanu C; Andronesi D; Popescu I; Herlea V
    Rom J Morphol Embryol; 2012; 53(2):351-5. PubMed ID: 22732805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival and prognostic factors in patients with small bowel carcinoid tumour.
    Landerholm K; Zar N; Andersson RE; Falkmer SE; Järhult J
    Br J Surg; 2011 Nov; 98(11):1617-24. PubMed ID: 21858790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
    Paralkar VR; Li T; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.